Drug therapy in HIV infection--fourth international congress. 8-12 November 1998, Glasgow, Scotland.
This meeting was one of a series which is held in Glasgow on a biannual basis. The major themes of the conference were the use of combination therapy to reduce viral replication in HIV infected individuals and the successes and failures of various treatment regimens; the issue of viral sequestration in sanctuary sites over long periods in the context of non-susceptibility to antiviral therapy due to viral latency and other considerations; drug resistance to antiviral therapy and how to prevent this problem from occurring; immune-based therapeutic approaches in the treatment of HIV disease; and, the development of treatment strategies for individuals who have failed on their initial antiviral regimens. The majority of delegates at this conference were HIV clinicians involved in direct patient contact. The meeting also included the participation of HIV community workers, representatives of the pharmaceutical industry, as well as research scientists concerned with basic mechanisms of HIV pathogenesis, drug resistance and other issues. Most of the presentations were from academic physicians involved in a variety of HIV clinical trials, although pharmaceutical scientists, who specialize in the development of techniques to monitor drug resistance, also featured prominently in the program. Both oral papers and poster sessions were featured.